Caseware UK (AP4) 2025.0.111 2025.0.111 2026-02-282026-02-28false2025-03-01trueNo description of principal activity00true 04355378 2025-03-01 2026-02-28 04355378 2024-03-01 2025-02-28 04355378 2026-02-28 04355378 2025-02-28 04355378 c:Director1 2025-03-01 2026-02-28 04355378 c:EntityHasNeverTraded 2025-03-01 2026-02-28 04355378 c:AuditExempt-NoAccountantsReport 2025-03-01 2026-02-28 04355378 c:FullAccounts 2025-03-01 2026-02-28 04355378 c:PrivateLimitedCompanyLtd 2025-03-01 2026-02-28 04355378 c:Micro-entities 2025-03-01 2026-02-28 04355378 d:PoundSterling 2025-03-01 2026-02-28 iso4217:GBP xbrli:pure
Registered number: 04355378


OSTEOCARE INTERNATIONAL LIMITED
UNAUDITED
FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR
FOR THE YEAR ENDED 28 FEBRUARY 2026




 
OSTEOCARE INTERNATIONAL LIMITED
REGISTERED NUMBER: 04355378

BALANCE SHEET
AS AT 28 FEBRUARY 2026

2026
2025
£
£


Called up share capital not paid
2
2

Total assets less current liabilities
2
2


Net assets
2
2



Capital and reserves
2
2


Notes


General information

The company is a private limited company, having a share capital, registered in England and Wales, company
registration number 04355378. The registered office is situated at 1a High Street, Epsom, Surrey KT19 8DA.


Average number of employees

The average monthly number of employees, including directors, during the year was 0 (2025 - 0).

The Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

The members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 5 October 2026.







C A Gauld
Director

Page 1